Expression of CD226 is upregulated on Tr1 cells from neuromyelitis optica spectrum disorder patients

Abstract Background Neuromyelitis optica spectrum disorder (NMOSD) is a central and acute demyelinating disease of the central nervous system with unusual clinical course. The development of novel biomarkers for NMOSD is critical for implementing effective clinical treatment. CD226 is known to be ex...

詳細記述

書誌詳細

出版年:	Brain and Behavior
主要な著者:	Ping Chen, Mingmei Wu, Ning Wang, Feng Xia, Fang Du, Zhirong Liu, Jinchun Wang, Jingyi Jin, Boquan Jin, Gang Zhao, Lihua Chen, Jing Yi, Liang Fang
フォーマット:	論文
言語:	英語
出版事項:	Wiley 2022-06-01
主題:	biomarker CD226 NMOSD Tr1 cell
オンライン･アクセス:	https://doi.org/10.1002/brb3.2623